-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E0Ey1NjtZKLxK6MsW/2mR+fFEDjy+wgamdl7gdq4ULfALVZ4X7z7zgd96Pw7XULI R4+3Y7WAtJ97ihTqSXrj7Q== 0001014865-96-000001.txt : 19960531 0001014865-96-000001.hdr.sgml : 19960531 ACCESSION NUMBER: 0001014865-96-000001 CONFORMED SUBMISSION TYPE: 8-A12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960530 SROS: NONE FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMARILLO BIOSCIENCES INC CENTRAL INDEX KEY: 0001014763 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-A12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-20791 FILM NUMBER: 96574833 BUSINESS ADDRESS: STREET 1: 800 WEST 9TH AVENUE CITY: AMARILLO STATE: TX ZIP: 79101-3206 BUSINESS PHONE: 8063761741 8-A12G 1 FORM 8-A FOR AMARILLO BIOSCIENCES, INC. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------- FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(B) OR 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 Amarillo Biosciences, Inc. - ------------------------------------------------------------------------------- (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) Texas 75-1974352 - --------------------------------------------- ------------------------ (STATE OF INCORPORATION OR ORGANIZATION) (I.R.S. EMPLOYER IDENTIFICATION NO.) 800 West 9th Avenue, Amarillo, Texas 79101 - --------------------------------------------- ------------------------ (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE) If this Form relates to the If this Form relates to the registration of a class of debt registration of a class of debt securities and is effective upon securities and is to become effective filing pursuant to General simultaneously with the Instruction A(c)(1) please check the effectiveness of a concurrent following box. |_| registration statement under the Securities Act of 1933 pursuant to General Instruction A(c)(2) please check the following box. |_| Securities to be registered pursuant to Section 12(b) of the Act: TITLE OF EACH CLASS NAME OF EACH EXCHANGE ON WHICH TO BE SO REGISTERED EACH CLASS IS TO BE REGISTERED - --------------------------- --------------------------------- SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(G) OF THE ACT: Common Stock, par value $.01 per share - ------------------------------------------------------------------------------- (TITLE OF CLASS) - ------------------------------------------------------------------------------- (TITLE OF CLASS) PAGE 1 OF 3 PAGES Item 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED This Registration Statement relates to the Common Stock, par value $.01 per share (the "Common Stock"), of Amarillo Biosciences, Inc., a Texas corporation (the "Registrant"). A Registration Statement on Form SB-2 (Registration No. 333-04413) relating to an offering of up to 2,300,000 shares of Common Stock (the "Registration Statement") was filed with the Securities and Exchange Commission on May 23, 1996, pursuant to the Securities Act of 1933, as amended (the "Securities Act"). The description of the Common Stock to be contained in the final Prospectus to be filed by the Registrant pursuant to Rule 424(b) under the Securities Act shall be deemed incorporated herein by reference. ITEM 2. EXHIBITS 1. Restated Articles of Incorporation of the Registrant. Incorporated by reference to Exhibit 3.2 to the Registration Statement. 2. By-laws of the Registrant. Incorporated by reference to Exhibit 3.3 to the Registration Statement. SIGNATURE Pursuant to the requirements of Section 12 of the Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized. Date: May 30, 1996 AMARILLO BIOSCIENCES, INC. By: /s/ Joseph Cummins Joseph Cummins, Chairman of the Board, President and Chief Executive Officer -----END PRIVACY-ENHANCED MESSAGE-----